FR2214480A1 - Antiallergic, anti-inflammatory compsns. - for treating e.g. asthma and gastro intestinal allergies - Google Patents

Antiallergic, anti-inflammatory compsns. - for treating e.g. asthma and gastro intestinal allergies

Info

Publication number
FR2214480A1
FR2214480A1 FR7402012A FR7402012A FR2214480A1 FR 2214480 A1 FR2214480 A1 FR 2214480A1 FR 7402012 A FR7402012 A FR 7402012A FR 7402012 A FR7402012 A FR 7402012A FR 2214480 A1 FR2214480 A1 FR 2214480A1
Authority
FR
France
Prior art keywords
cpd
inflammatory
xanthone
pref
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7402012A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of FR2214480A1 publication Critical patent/FR2214480A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86—Oxygen atoms, e.g. xanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
FR7402012A 1973-01-23 1974-01-22 Antiallergic, anti-inflammatory compsns. - for treating e.g. asthma and gastro intestinal allergies Withdrawn FR2214480A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB335273 1973-01-23
GB1788673 1973-04-13
GB2182273 1973-05-08
GB4611673 1973-10-03
GB5420273 1973-11-22

Publications (1)

Publication Number Publication Date
FR2214480A1 true FR2214480A1 (en) 1974-08-19

Family

ID=27515722

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7402012A Withdrawn FR2214480A1 (en) 1973-01-23 1974-01-22 Antiallergic, anti-inflammatory compsns. - for treating e.g. asthma and gastro intestinal allergies

Country Status (5)

Country Link
JP (1) JPS49102826A (enExample)
DE (1) DE2403055A1 (enExample)
FR (1) FR2214480A1 (enExample)
IL (1) IL44022A0 (enExample)
NL (1) NL7400827A (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL51314A (en) * 1976-01-30 1980-03-31 Fisons Ltd Disodium cromoglycate of low moisture content and pharmaceutical compositions containing it
GB1582362A (en) * 1977-03-17 1981-01-07 Fisons Ltd Cromoglycic acid salts and compositions
AU522792B2 (en) * 1977-07-19 1982-06-24 Fisons Plc Pressure pack formulation

Also Published As

Publication number Publication date
JPS49102826A (enExample) 1974-09-28
IL44022A0 (en) 1974-05-16
NL7400827A (enExample) 1974-07-25
DE2403055A1 (de) 1974-07-25

Similar Documents

Publication Publication Date Title
DE69738935D1 (de) Zusammensetzungen enthaltend Thalidomide und Dexamethason für die Behandlung von Krebs
ES557179A0 (es) Sistema para la administracion transdermica de un farmaco seleccionado del grupo formado por fentanil y sus derivados analgesicamente eficaces
MX23949A (es) Compuestos diaza, y procedimiento para su preparaion y compociciones farmaceuticas anti-hipertesivay para el tratamiento de enfermedades cardiacas que los incluye.
ATE47035T1 (de) Kit oder vorrichtung und methode zum verabreichen von gangliosiden und deren derivate durch inhalation und dafuer geeignete pharmazeutische zusammensetzungen.
BE810004A (en) Antiallergic, anti-inflammatory compsns. - for treating e.g. asthma and gastro intestinal allergies
FI891210A0 (fi) Tiosulfinsyraderivat, deras anvaendning vid inflammationssjukdomar samt laekemedel innehaollande dessa aemnen.
NL181780C (nl) Farmaceutisch combinatiepreparaat voor de therapie en profylaxe van malaria.
AT304515B (de) Verfahren zur Herstellung von neuen Fluoren- bzw. Fluorenonderivaten bzw. von pharmazeutisch verträglichen Säureadditionssalzen hievon
IT1055176B (it) Procedimento per rimuovere rive stimenti di allominuro da ggetti
MX9300057A (es) Ester especial del acido 1,4-dihidropiridin-3,5-dicarboxilico y procedimiento para su obtencion.
FR672025A (fr) Procédé de préparation de cyclo-hexen aldéhydes alcoylées, d'acides cyclo-hexen-carboniques alcoylés et de leurs esters
IT8322949A0 (it) Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello.
FR2112398A1 (en) Coccidiostatic poultry feeds - contg 1,3-bis(p-chlorbenzylidineamino)
GT197537486A (es) Procedimiento para la preparacion de 2-oxo -1- pirrolidino--acetamida.
BE767803A (fr) Preparation pharmaceutique pour le traitement de troubles digestifs et procede de traitement de ceux-ci
FR33174E (fr) Système de verrouillage des portes-palières d'ascenseurs
FR2208655A1 (en) Anti allergic disodiumcromoglycate administration - using dosage scheme which gives sensitisation dose followed by lesser supporting dose
FR1044948A (fr) Baignoire à translation électro-mécanique des blessés pour le traitement des brûlures graves
FR632330A (fr) Boulon d'écrou de sûreté
FR635717A (fr) Procédé catalytique pour l'oxydation de substances organiques et minérales
FR662096A (fr) Procédé pour la préparation d'oxyaldéhydes aromatiques
FR2115057A2 (en) 2-alpha-2-beta-17-alpha trimethyl-13-beta-ethylgona - -4,9,11-triene-3-ones as anti androgenics
Torda Central neuro-humoral mechanism initiating sleep, paradoxical sleep, and dreaming.
FR2978M (fr) Association thérapeutique pour traitement étiologique ou symptomatique de nombreuses dyspepsies et affections digestives dites organiques ou fonctionnelles.
ES104299A3 (es) Procedimiento para la fabricación de pastillas o comprimidos para la preparación de baños higiénicos o medicinales.

Legal Events

Date Code Title Description
ST Notification of lapse